Medicare Enrolled
Dr. David Miller, M.D.
Retina Specialist (Ophthalmology) Physician · Beachwood, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Miller from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Miller?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Miller
Dr. David Miller is a retina specialist physician in Beachwood, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Miller performed 28,479 Medicare services across 5,274 unique beneficiaries.
Between the years covered by Open Payments, Dr. Miller received a total of $250,617 from 26 pharmaceutical and/or device companies across 407 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in retina specialist (ophthalmology) physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Miller is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 16% volume in OH
$250,617 industry payments
Medicare Practice Summary
Medicare Utilization ↗28,479
Medicare services
Top 16% in OH for retina specialist (ophthalmology) physician
5,274
Unique beneficiaries
$167
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,424 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) An injection of faricimab-svoa, a medication administered in 0.1 mg doses. |
10,740 | $29 | $76 |
| Aflibercept eye injection (Eylea) | 3,842 | $691 | $1,799 |
| Pegcetacoplan intravitreal injection, 1 mg An injection of pegcetacoplan administered into the vitreous humor of the eye. The dose specified is 1 milligram. |
3,450 | $120 | $308 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
3,102 | $27 | $78 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
2,173 | $93 | $284 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
1,483 | $80 | $242 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
648 | $62 | $204 |
| Triamcinolone acetonide injection, 1 mg An injection of triamcinolone acetonide, a corticosteroid medication, administered in a 1 mg dose. |
558 | $37 | $48 |
| Dexamethasone intravitreal implant injection An injection of a dexamethasone implant placed inside the eye. This procedure delivers medication directly into the vitreous cavity of the eye. |
441 | $159 | $400 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
330 | $1,763 | $4,635 |
| Extended exam of back of eye with optic nerve drawing A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing. |
299 | $10 | $32 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
299 | $26 | $73 |
| Injection, ranibizumab, 0.1 mg | 155 | $186 | $481 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
151 | $113 | $324 |
| Extended eye exam with retinal drawing A detailed examination of the back of the eye that includes creating a drawing of the retina. |
149 | $17 | $48 |
| Unclassified biologic A biologic product that does not have a specific HCPCS code assigned. |
138 | $452 | $1,793 |
| Retinal angiography with dye injection This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body. |
120 | $99 | $260 |
| Retinal laser destruction of growth A laser procedure used to destroy abnormal growths in the retina. |
63 | $382 | $985 |
| New patient office visit, complex (60-74 min) | 61 | $148 | $428 |
| Retinal laser treatment for leaking blood vessels This procedure uses a laser to seal leaking blood vessels in the retina. It is performed to prevent vision loss caused by fluid leakage from damaged retinal vessels. |
44 | $249 | $2,000 |
| Retinal membrane and internal limiting membrane removal A surgical procedure to remove a membrane from the retina along with the internal limiting membrane of the retina. |
40 | $855 | $2,187 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
30 | $80 | $248 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
30 | $119 | $348 |
| Injection into suprachoroidal space of eye A procedure involving the injection of medication into the space located above the choroid membrane of the eye. |
22 | $85 | $821 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
22 | $65 | $178 |
| Vitreous removal between lens and retina This procedure involves the removal of the vitreous fluid located between the lens and the retina of the eye. |
21 | $625 | $1,710 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
20 | $99 | $286 |
| Retinal photocoagulation to prevent detachment This procedure uses laser light to create small burns on the retina. It is performed to help prevent the retina from detaching from the back of the eye. |
19 | $170 | $521 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
16 | $43 | $120 |
| Removal of implant material from inside of eye This procedure involves the surgical removal of implant material located within the interior of the eye. |
13 | $623 | $1,722 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$250,617
Total received (2018-2024)
Avg $35,802/year across 7 years
Top 14% in OH for retina specialist (ophthalmology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
407
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$149,168 (59.5%)
Other
Charitable contributions, space rental, and other categories
$42,587 (17.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$31,358 (12.5%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$19,798 (7.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,706 (3.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$49,989
2023
$18,926
2022
$68,579
2021
$32,772
2020
$35,044
2019
$27,201
2018
$18,106
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$29,012
Astellas Pharma US Inc
$19,127
ABBVIE INC.
$377
Genentech USA, Inc.
$345
Alimera Sciences, Inc.
$297
Apellis Pharmaceuticals, Inc.
$280
Dutch Ophthalmic, USA
$279
Regeneron Pharmaceuticals, Inc.
$108
Sandoz Inc.
$54
Ocular Therapeutix, Inc.
$50
Harrow Eye, LLC
$40
Coherus Biosciences Inc.
$21
Top 3 companies account for 97.1% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Healthcare Solutions, Inc.
$155,973
US Retina LLC
$62,386
Astellas Pharma US Inc
$22,108
Allergan, Inc.
$2,694
Genentech USA, Inc.
$1,161
Dutch Ophthalmic, USA
$1,114
Apellis Pharmaceuticals, Inc.
$934
ABBVIE INC.
$903
Alimera Sciences, Inc.
$722
Allergan Inc.
$684
Coherus Biosciences Inc.
$363
Novartis Pharmaceuticals Corporation
$272
Alcon Vision LLC
$270
EyePoint Pharmaceuticals US, Inc.
$196
Mallinckrodt Hospital Products Inc.
$147
Bausch & Lomb Americas Inc.
$114
Bausch & Lomb, a division of Bausch Health US, LLC
$109
Regeneron Pharmaceuticals, Inc.
$108
Carl Zeiss Meditec, Inc.
$104
Biogen, Inc.
$55
Sandoz Inc.
$54
Ocular Therapeutix, Inc.
$50
Harrow Eye, LLC
$40
Genentech, Inc.
$24
Horizon Therapeutics plc
$19
AbbVie, Inc.
$13
Top 3 companies account for 95.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · BEOVU · CIRRUS HD-OCT · Centurion · Cimerli · DEXTENZA · DEXYCU · EVA · EVA Ophthalmic Surgical System · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · Humira · ILUVIEN · Iluvien · Izervay · Lucentis · NGENUITY · OZURDEX · STELLARIS PC · SUSVIMO · Susvimo · Syfovre · TEPEZZA · TRIESENCE · VABYSMO · Vabysmo · XIPERE · YUTIQ · combined machine
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (60%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in retina specialist (ophthalmology) physician and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Retina specialist physicians within 10 mi
9
Per 100K population
0.7
County median income
$62,823
Nearest hospital
SOUTH POINTE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Miller is a mixed practice specialist, with above-average Medicare volume (top 16% in OH), with speaking/promotional industry engagement in the top 14% of OH peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Miller experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Miller performed 10,740 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Miller receive payments from pharmaceutical companies?
Yes. Dr. Miller received a total of $250,617 from 26 companies across 407 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Miller's costs compare to other retina specialist physicians in Beachwood?
Dr. Miller's average Medicare payment per service is $167. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Miller) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Retina Specialist Physicians in Beachwood
Browse retina specialist physicians in Beachwood ranked by procedure volume and transparency data.
Highest volume
Top Retina Specialist Physicians in OH
Retina specialist physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Retina Specialist Physicians in OH
Which OH retina specialist physicians receive the most from drug and device companies.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
By company
US Retina LLC Payments to Doctors
See all physicians who received payments from US Retina LLC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology